Template:Clinically Utilized Antibiotics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
* [[Vancomycin]] | * [[Vancomycin]] | ||
* [[Teicoplanin]] ([[Dalbavancin]]) | * [[Teicoplanin]] ([[Dalbavancin]]) | ||
|group3 = β-lactams | |group3 = β-lactams | ||
| Line 26: | Line 25: | ||
| groupstyle = background:PowderBlue; | | groupstyle = background:PowderBlue; | ||
| group1 = | | group1 = Natural | ||
| list1 = | | list1 = | ||
* | * [[Amoxicillin]] | ||
* [[Ampicillin]] | * [[Ampicillin]] | ||
|group2 | | group2 = Antistaphylococcal | ||
|list2 | | list2 = | ||
* [[Cloxacillin]] ([[Dicloxacillin]] | * [[Cloxacillin]] ([[Dicloxacillin]] | ||
* [[Flucloxacillin]]) | * [[Flucloxacillin]]) | ||
| Line 60: | Line 39: | ||
* [[Nafcillin]] | * [[Nafcillin]] | ||
| | | group3 = Amino-Penicillins | ||
| | | list3 = | ||
* [[Amoxicillin/clavulanic acid]] | * [[Amoxicillin/clavulanic acid]] | ||
* [[Ampicillin/flucloxacillin]] | * [[Ampicillin/flucloxacillin]] | ||
* [[Ampicillin/sulbactam]] ([[Sultamicillin]]) | * [[Ampicillin/sulbactam]] ([[Sultamicillin]]) | ||
| group4 = Anti-Pseudomonal | |||
| list4 = | |||
* [[Ticarcillin]] | |||
* [[Piperacillin/tazobactam]] | * [[Piperacillin/tazobactam]] | ||
}} | }} | ||
Revision as of 22:16, 10 February 2014
| ||||||||||||||||||||||||||||||||||||||||||||||||||
hlist
How to manage this template's visibility
- Use
{{Clinically Utilized Antibiotics |state=collapsed}}to show this template in its collapsed (hidden) state. - Use
{{Clinically Utilized Antibiotics |state=expanded}}to show this template in its expanded (fully visible) state. - Use
{{Clinically Utilized Antibiotics |state=autocollapse}}to show this template in its collapsed (hidden) state only if there is another template of the same type on the page. - Unless set otherwise (see state parameter within the template's code), autocollapse is the default state.